NESSUM-ALLIANCE
21.5.2024 10:01:27 CEST | Business Wire | Press release
In a groundbreaking stride toward advancing communication standards in the digital age, the NESSUM Alliance is proud to announce the release of the IEEE 1901c standard on May 15th. This transformative standard, created from the collaborative efforts of NESSUM's esteemed members, now stands poised to redefine connectivity paradigms worldwide, under the rebranded banner of NESSUM.
With the introduction of IEEE 1901c, formerly known as 'HD-PLC,' NESSUM introduces many new and unparalleled features:
- Long-Distance Communication: Spanning several kilometers, NESSUM enables a new era of expansive reach.
- Broadband Communication: Operating in the Mbps class, this standard ensures seamless transmission of data across networks.
- IP Compatibility: Using standardized Internet Protocol (IP), NESSUM seamlessly integrates with existing infrastructures.
- Topology-Free Configuration: Facilitating flexible networking, NESSUM overcomes conventional constraints of network configurations.
- Safety and Security: Prioritizing network and user safety, NESSUM ensures robust and secure communication channels.
Besides high-speed communication on any wire, NESSUM technology also enables the transmission of weak radio signals, facilitating short-range wireless communication applications, including underwater environments. This makes it a truly versatile solution for any media.
The IEEE began the development of the any medium communication standard for IoT applications as IEEE P1901c in May 2022, including the adoption of the Wavelet OFDM method - one of the advanced feature sets of NESSUM's technological advantages compare to other (power line) solutions. After months of effort and refinement, IEEE 1901c attained formal approval in February of this year, marking a monumental leap forward in communication standards.
Mr. Jean-Philippe Faure, Chair of the IEEE 1901WG, lauded the contributions of NESSUM Alliance's expert members, affirming, "This new standard expands the application range of powerline communication to various existing lines and supports low-power radio, opening up new possibilities for high-speed short-range wireless communication."
Agreeing to this sentiment, Mr. Hiroshi Saijo, Head of Business Development & Strategy at Panasonic Holdings Corporation, articulated a shared vision of global proliferation, stating, "We aim to spread this IoT communication standard worldwide as an international standard, not only in products but also in applications."
Mr. Keishi Kajiwara, Director of the Communication Business Division at MegaChips Corporation expressed eager anticipation for market expansion and collaborative endeavors with the new standard, NESSUM's pivotal role in driving innovation.
Mr. Christopher Trabold, CTO and Business Development Leader for Asset Monitoring and Communication at General Electric Vernova, emphasized the burgeoning demand for powerline communication with the digitalization of power infrastructure, signaling a promising trajectory for IEEE 1901c.
IEEE 1901c's transformative capabilities extend to long-distance powerline communication, now covering the several hundred kHz band as NBPLC through innovative resampling. This evolutionary leap finds resonance in diverse sectors, from medium-voltage system control to smart meters, with new applications in Asia and beyond.
Mr. Markus Rindchen, Head of Technology Management at Power Plus Communications AG, pointed out the indispensable role of NESSUM in Germany's Smart Meter Gateway business, underscoring its essential role for the mass roll-out.
Mr. Tomislav Drenski, Marketing Manager at Socionext Europe GmbH is excited to promote the new NESSUM ICs. These advanced ICs offer unique features such as high speed, stable and secure long-distance communication, which surpass other power line solutions available in the market.
With a strong long-term commitment to meet evolving market demands and continuously develop innovation in the IoT landscape, the NESSUM Alliance promotes and supports Any Media communications being inter-operable worldwide. Through a multifaceted approach encompassing webinars, seminars, exhibitions, and extensive promotional activities, the alliance is confident and certain to drive future state-of-the-art solutions with increased compatibility, and lead international standardization efforts.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240521360203/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Announces New Positive 54-Week Late-Breaking Data for Povorcitinib in Hidradenitis Suppurativa at the 2026 American Academy of Dermatology (AAD) Annual Meeting28.3.2026 20:00:00 CET | Press release
Phase 3 data from the STOP-HS program demonstrate povorcitinib’s substantial and durable clinical efficacy through Week 54 in patients with moderate to severe hidradenitis suppurativa (HS). Through Week 54, clinically meaningful and durable responses were observed across all groups in both STOP-HS1 and STOP-HS2, with up to 71.4% of patients achieving HiSCR50. Improvements in clinical responses across high stringent thresholds were observed, with up to 57% of participants achieving HiSCR75 and up to 29% of participants achieving HiSCR100. Povorcitinib treatment led to consistent reductions across key inflammatory lesion types, with full resolution (ANdT=0) achieved in up to 20% of patients. Additionally, clinically meaningful improvements in quality-of-life measures, including skin pain and fatigue, were observed at Week 54. The overall safety profile of povorcitinib through 54 weeks is consistent with previously reported data, and both doses were well tolerated. Incyte (Nasdaq:INCY) to
Takeda’s Zasocitinib Delivered Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill, Affirming Promise to Reshape Psoriasis Care28.3.2026 20:00:00 CET | Press release
About 70% of patients treated with zasocitinib achieved clear or almost clear skin (sPGA 0/1) at week 16 in Phase 3 plaque psoriasis studies A significantly greater PASI 75 response rate versus placebo was observed as early as week 4 Safety profile consistent with Phase 2b studies with no new safety signals identified Takeda(TSE:4502/NYSE:TAK)today announced new data from the two pivotal Phase 3studies of zasocitinib (TAK-279), a next-generation, highly selective oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO).1 Presented as a late-breaking abstract at the 2026 American Academy of Dermatology (AAD) Annual Meeting, these data show that convenient once-daily oral zasocitinib demonstrated rapid and durable skin clearance with a safety profile consistent with Phase 2b studies.1,2 “Our goal in psoriasis treatment is clear or almost clear skin, and previously this has been achieved primarily with injectable therapies,” said Melinda Gooderham,
AAD 2026: Late-Breaking Nemolizumab Data Demonstrate Clinically Meaningful Benefits for Children Aged 2 to 11 With Moderate-to-Severe Atopic Dermatitis28.3.2026 16:00:00 CET | Press release
Pharmacokinetics, safety and efficacy clinical study data show that nemolizumab achieved clinically meaningful reductions in skin lesions and itch through Week 16, which were sustained up to a year in children aged 2 to 11 with moderate-to-severe atopic dermatitis1 These findings reinforce the previously established safety and efficacy of nemolizumab in adults and adolescents with moderate-to-severe atopic dermatitis, for which it is approved by multiple global regulatory authorities2,3 Up to 25% of children are affected by atopic dermatitis, and currently there are limited approved treatment options for children living with moderate-to-severe atopic dermatitis4,5 Galderma (SIX: GALD) today announced new phase II data showing that nemolizumab was well tolerated and effective in children (aged 2 to 11 years) with moderate-to-severe atopic dermatitis, with a clinically meaningful and sustained reduction in skin lesions and itch for up to a year.1 Results will be presented in a late-break
Angelalign Technology (6699.HK)Releases 2025 Results: Passion for Clinical Excellence Drives Worldwide Growth27.3.2026 20:56:00 CET | Press release
Angelalign Technology Inc. (6699.HK) (“Angel” or the “Company”) released its financial results for fiscal year 2025. During the reporting period, the Company continued to do well in both the global and China markets. Total case volume was 532,400, which increased 48.1%, revenue was USD 370.3 million, which increased 37.8%, and adjusted net profit was USD 43.8 million, which increased 63.0%. The results were driven by Angel’s passion for clinical excellence and its open and inclusive culture that empowers talented people to work together to meet customer needs, the Company said. Fox Hu, CEO of Angel, stated: “The clear aligner industry is complex and multidisciplinary. It requires top-tier technical and operational talent along with seamless collaboration among professionals from diverse geographies. Angel’s open and inclusive culture attracts professionals who share a passion for clinical excellence and a dedication to bringing outstanding products and services to customers. This melti
Axway Positioned as a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment27.3.2026 18:46:00 CET | Press release
Axway, a 74Software company (Euronext: 74SW) and global leader in federated API management and enterprise integration, has been named a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment.1 Axway Amplify securely connects, orchestrates, and automates data integration. Organizations in financial services, manufacturing, healthcare, and other industries rely on Amplify to modernize integrations and confidently unlock data to deliver superior digital services faster. The report notes: “The platform benefits from Axway’s long-standing experience in B2B integration, secure file transfer, and legacy connectivity, providing differentiated capabilities for organizations that need to expose and control APIs around core systems that are not cloud-native.”1 This multi-pattern expertise in security, integration, and federated governance — built during the early phases of the API-driven digital transformation — becomes especially critical as enterprises seek to govern dat
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
